---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-026395"
form_type: "8-K"
ticker: "HYPR"
cik: "0001833769"
company_name: "Hyperfine, Inc."
filed_at: "2022-12-12T23:59:59+00:00"
generated_at: "2026-06-21T06:20:11.835146+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Hyperfine cuts ~13% of workforce; expects up to $1.7M in restructuring costs

## Summary
- Terminated approximately 13% of global workforce, including employees of subsidiary Liminal Sciences.
- Estimated restructuring costs of up to $1.7M, mainly cash severance and fixed asset impairment.
- Restructuring expected to be substantially complete in Q4 2022 and Q1 2023.
- Actions aimed at reducing costs and streamlining operations.

## SEC filing metadata
- accession: 0000950170-22-026395
- form_type: 8-K
- ticker: HYPR
- cik: 0001833769
- company_name: Hyperfine, Inc.
- filed_at: 2022-12-12T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.05
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1833769/000095017022026395/0000950170-22-026395-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1833769/000095017022026395/hypr-20221206.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-026395
- JSON: https://secwatch.observer/filing/0000950170-22-026395.json
- Plain text: https://secwatch.observer/filing/0000950170-22-026395.txt

## Key facts
- Restructurings & Charges
  Hyperfine, Inc. announced a restructuring with charges of up to $1.7 million affecting global workforce, including subsidiary Liminal Sciences, Inc. (approximately 13% of its global workforce).
  - Type: restructuring
  - Charge: up to $1.7 million
  - Affected area: global workforce, including subsidiary Liminal Sciences, Inc.
  - Headcount: approximately 13% of its global workforce
  source text: On December 6, 2022, Hyperfine, Inc. (the “Company”) committed to an organizational restructuring designed to decrease its costs and create a more streamlined organization to support its business. As a result, the Company has terminated approximately 13% of its global workforce including, among others, the employees of its subsidiary, Liminal Sciences, Inc. In connection with the restructuring, the Company currently estimates it will incur up to $1.7 million of costs, consisting primarily of cash severance costs, other severance benefits, fixed asset impairment costs and other related restructuring costs.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1833769/000095017022026395/0000950170-22-026395-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.